Dr. Amy Jenkins Program Manager Biological Technologies Office

Dr. Amy Jenkins joined DARPA as a program manager in the Biological Technologies Office (BTO) in June 2019. Her interests include the development of platforms for combatting infectious disease threats as well as novel manufacturing methods to enable rapid response.

Prior to joining DARPA, Jenkins was a senior scientist at Gryphon Technologies, where she contributed to development of programs targeting infectious disease threats within BTO. Previously, Jenkins studied the virulence factors of, and antibodies targeting, multi-drug resistant bacterial pathogens at Me mune. She also served as a National Research Council postdoctoral fellow at the U.S. Army Medical Research Institute of Infectious Diseases, where she studied virulence mechanisms of biodefense pathogens.

Jenkins received her Doctor of Philosophy in chemistry and chemical biology from Cornell University and her Bachelor of Science in chemistry and biomolecular science from Clarkson University.

Presenting at:

All times are presented in the host university’s local time zone.

Wednesday, October 26, 2022

Preparing for Pandemic Threats in a Rapidly Changing World
(9:35am - 10:20am)

You are now leaving the website that is under the control and management of DARPA. The appearance of hyperlinks does not constitute endorsement by DARPA of non-U.S. Government sites or the information, products, or services contained therein. Although DARPA may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.

After reading this message, click  to continue immediately.

Go Back